$ATOM
Atomera Inc Stock $atom

$atom Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000168316823002651 Filed on April 26, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$0.00	$0.00	$375.0K
YoY Change		-100.0%	-6.25%
Cost Of Revenue	$0.00	$0.00	$81.00K
YoY Change		-100.0%
Gross Profit	$0.00	$0.00	$294.0K
YoY Change		-100.0%	-26.5%
Gross Profit Margin			78.4%
Selling, General & Admin	$2.168M	$2.131M	$1.973M
YoY Change	7.65%	8.01%	10.84%
% of Gross Profit			671.09%
Research & Development	$3.192M	$3.036M	$2.339M
YoY Change	31.2%	29.8%	4.89%
% of Gross Profit			795.58%
Depreciation & Amortization	$310.0K	$20.00K	$20.00K
YoY Change	1531.58%	0.0%	100.0%
% of Gross Profit			6.8%
Operating Expenses	$5.360M	$5.167M	$4.312M
YoY Change	20.53%	19.83%	7.53%
Operating Profit	-$5.360M	-$5.167M	-$4.018M
YoY Change	20.53%	28.6%	11.3%
Interest Expense	$101.0K	$53.00K	-$68.00K
YoY Change	46.38%	-177.94%
% of Operating Profit
Other Income/Expense, Net	$107.0K	$148.0K	-$68.00K
YoY Change	-414.71%	-317.65%
Pretax Income	-$5.152M	-$5.019M	-$4.086M
YoY Change	14.97%	22.83%	13.19%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$5.152M	-$5.019M	-$4.086M
YoY Change	14.97%	22.83%	12.87%
Net Earnings / Revenue			-1089.6%
Basic Earnings Per Share	-$0.21	-$0.21	-$0.18
Diluted Earnings Per Share	-$0.21	-$0.21	-$178.8K
COMMON SHARES
Basic Shares Outstanding	24.41M shares	23.97M shares	22.85M shares
Diluted Shares Outstanding	24.68M shares	23.66M shares	22.85M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.84M	$17.05M	$24.45M
YoY Change	9.14%	-30.26%	-33.45%
Cash & Equivalents	$12.90M	$12.12M	$24.45M
Short-Term Investments	$10.93M	$4.934M
Other Short-Term Assets	$650.0K	$303.0K	$846.0K
YoY Change	0.0%	-64.18%	4.44%
Inventory
Prepaid Expenses
Receivables			$300.0K
Other Receivables			$0.00
Total Short-Term Assets	$24.54M	$17.36M	$25.60M
YoY Change	9.1%	-32.2%	-31.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.349M	$153.0K	$6.574M
YoY Change	2371.02%	-97.67%	443.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$105.0K	$105.0K	$105.0K
YoY Change	0.0%	0.0%	-77.17%
Total Long-Term Assets	$4.454M	$4.780M	$6.679M
YoY Change	-29.23%	-28.43%	299.94%
TOTAL ASSETS
Total Short-Term Assets	$24.54M	$17.36M	$25.60M
Total Long-Term Assets	$4.454M	$4.780M	$6.679M
Total Assets	$28.99M	$22.14M	$32.28M
YoY Change	0.72%	-31.42%	-17.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$562.0K	$423.0K	$380.0K
YoY Change	29.49%	11.32%	-25.49%
Accrued Expenses	$1.055M	$242.0K	$718.0K
YoY Change	395.31%	-66.3%	5.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.357M	$1.240M	$1.396M
YoY Change	-2.72%	-11.17%
Total Short-Term Liabilities	$2.974M	$2.444M	$2.494M
YoY Change	6.4%	-2.0%	109.58%
LONG-TERM LIABILITIES
Long-Term Debt	$2.376M	$2.683M	$3.870M
YoY Change	-33.61%	-30.67%
Other Long-Term Liabilities	$400.0K	$475.0K	$725.0K
YoY Change	-39.21%	-34.48%	-18.54%
Total Long-Term Liabilities	$2.776M	$3.158M	$4.595M
YoY Change	-34.48%	-31.27%	416.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.974M	$2.444M	$2.494M
Total Long-Term Liabilities	$2.776M	$3.158M	$4.595M
Total Liabilities	$5.750M	$5.602M	$7.089M
YoY Change	-18.23%	-20.98%	240.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$193.5M	-$188.3M
YoY Change	10.92%
Common Stock	$216.7M	$204.8M
YoY Change	10.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.24M	$16.53M	$25.19M
YoY Change
Total Liabilities & Shareholders Equity	$28.99M	$22.14M	$32.28M
YoY Change	0.72%	-31.42%	-17.85%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$5.152M	-$5.019M	-$4.086M
YoY Change	14.97%	22.83%	12.87%
Depreciation, Depletion And Amortization	$310.0K	$20.00K	$20.00K
YoY Change	1531.58%	0.0%	100.0%
Cash From Operating Activities	-$3.938M	-$4.234M	-$4.111M
YoY Change	57.27%	2.99%	4.34%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	$15.00K	-$16.00K
YoY Change	-200.0%	-193.75%	-20.0%
Acquisitions
YoY Change
Other Investing Activities	-$5.911M	-$4.942M
YoY Change
Cash From Investing Activities	-$5.914M	-$4.957M	-$16.00K
YoY Change	197033.33%	30881.25%	-20.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.64M	$125.0K	-121.0K
YoY Change	-10135.85%	-203.31%	-104.38%
NET CHANGE
Cash From Operating Activities	-3.938M	-$4.234M	-4.111M
Cash From Investing Activities	-5.914M	-$4.957M	-16.00K
Cash From Financing Activities	10.64M	$125.0K	-121.0K
Net Change In Cash	786.0K	-$9.066M	-4.248M
YoY Change	-130.08%	113.42%	254.0%
FREE CASH FLOW
Cash From Operating Activities	-$3.938M	-$4.234M	-$4.111M
Capital Expenditures	$3.000K	$15.00K	-$16.00K
Free Cash Flow	-$3.941M	-$4.249M	-$4.095M
YoY Change	57.58%	3.76%	4.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	atom	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2022Q4	atom	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	648000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	700000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3874000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4164000	usd
CY2023Q1	us-gaap	Assets Assets	22135000	usd
CY2022Q4	us-gaap	Assets Assets	26729000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	423000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	397000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	242000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	173000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	292000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	967000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	247000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	245000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1240000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1126000	usd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 280
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Gatos
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95032
CY2023Q1	dei	City Area Code CityAreaCode	(408)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	442-5248
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock: Par value $0.001
CY2023Q1	dei	Trading Symbol TradingSymbol	ATOM
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24412076	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12118000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21184000	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001420520
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37850
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ATOMERA INCORPORATED
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0509586
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	750 University Avenue
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	4934000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	303000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	418000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	17355000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21602000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	153000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	158000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28699000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2444000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2908000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	475000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	521000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2683000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2986000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5602000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6415000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24330000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24330000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23973000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23973000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	204825000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	203585000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188314000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183295000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16533000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22135000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26729000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	375000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	81000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	0	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	294000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3036000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2339000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1742000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1648000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	389000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	325000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5167000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4312000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5167000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4018000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	199000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	53000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	71000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	148000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-68000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4086000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23660000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22853000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23660000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22853000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4086000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5021000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4086000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	927000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	274000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-2000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16533000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	28381000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	726000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	166000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4086000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	25187000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4086000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	52000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	50000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	291000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	319000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	927000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	726000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-3000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	300000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-122000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	537000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	26000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	42000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	69000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	38000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-675000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-341000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-44000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-42000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4234000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4111000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	usd
CY2023Q1	atom	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	4942000	usd
CY2022Q1	atom	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4957000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16000	usd
CY2023Q1	atom	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	274000	usd
CY2022Q1	atom	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	39000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	166000	usd
CY2023Q1	atom	Payments On Principal Of Financing Lease PaymentsOnPrincipalOfFinancingLease	188000	usd
CY2022Q1	atom	Payments On Principal Of Financing Lease PaymentsOnPrincipalOfFinancingLease	287000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	125000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-121000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9066000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4248000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21184000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12118000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24451000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	53000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	71000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_804_eus-gaap--NatureOfOperations_zzVabXXlY6U9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_827_zMFcbC2huks7">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only recently begun limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits.</p>
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	17100000	usd
CY2023Q1	atom	Working Capital WorkingCapital	14900000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	46000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	0	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	375000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	375000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3956000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3502000	shares
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M18D
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	291000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	319000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	53000	usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	71000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	344000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	390000	usd
CY2023Q1	atom	Fixed Lease Costs FixedLeaseCosts	62000	usd
CY2022Q1	atom	Fixed Lease Costs FixedLeaseCosts	62000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	297000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	359000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	73000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	56000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	54000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	241000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	359000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	927000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	726000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	375000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	297000	shares

Files In Submission

Name	View Source	Status
0001683168-23-002651-index-headers.html	Edgar Link	pending
0001683168-23-002651-index.html	Edgar Link	pending
0001683168-23-002651.txt	Edgar Link	pending
0001683168-23-002651-xbrl.zip	Edgar Link	pending
atom-20230331.xsd	Edgar Link	pending
atomera_ex3101.htm	Edgar Link	pending
atomera_ex3102.htm	Edgar Link	pending
atomera_ex3201.htm	Edgar Link	pending
atomera_i10q-33123.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
atom-20230331_cal.xml	Edgar Link	unprocessable
atom-20230331_lab.xml	Edgar Link	unprocessable
atom-20230331_pre.xml	Edgar Link	unprocessable
atom-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atomera_i10q-33123_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATOM
Atomera Inc Stock $atom

2023 Q2 Form 10-Q Financial Statement

#000168316823002651 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM Atomera Inc Stock $atom

2023 Q2 Form 10-Q Financial Statement

#000168316823002651 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM
Atomera Inc Stock $atom